BRAF and melanoma: For patients with BRAFV600 mutant melanoma, BRAF and MEK inhibitors offer likewise excellent treatment options (McArthur et al. 2014; Hauschild et al. 2012; Rogiers et al. 2019; Long et al. 2017, 2014).